Works matching DE "EUROPEAN Federation of Pharmaceutical Industries %26 Associations (Organization)"
Results: 18
EFPIA has Avastin doubts.
- Published in:
- Optometry Times, 2015, v. 7, n. 10, p. 14
- Publication type:
- Article
EFPIA REPORT PINPOINTS RISKS FROM EMA RELOCATION.
- Published in:
- Applied Clinical Trials, 2017, v. 26, n. 9/10, p. 15
- By:
- Publication type:
- Article
Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Commentary on the MID3 Good Practices Paper.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2017, v. 6, n. 7, p. 416, doi. 10.1002/psp4.12223
- By:
- Publication type:
- Article
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4-5 December 2014).
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2017, v. 6, n. 7, p. 418, doi. 10.1002/psp4.12196
- By:
- Publication type:
- Article
INTELLECTUAL PROPERTY RIGHTS (IPR) IN COLLABORATIVE DRUG DEVELOPMENT IN THE EU: HELPING A EUROPEAN PUBLIC-PRIVATE PARTNERSHIP DELIVER - THE NEED FOR A FLEXIBLE APPROACH TO IPR.
- Published in:
- Marquette Intellectual Property Law Review, 2014, v. 18, n. 1, p. 31
- By:
- Publication type:
- Article
Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations.
- Published in:
- Drug Safety, 2021, v. 44, n. 1, p. 17, doi. 10.1007/s40264-020-01008-0
- By:
- Publication type:
- Article
The Innovative Medicines Initiative: A European Response to the Innovation Challenge.
- Published in:
- Clinical Pharmacology & Therapeutics, 2012, v. 91, n. 3, p. 418, doi. 10.1038/clpt.2011.321
- By:
- Publication type:
- Article
The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2016, v. 71, n. 2, p. 290, doi. 10.1093/jac/dkv339
- By:
- Publication type:
- Article
Looking to the Life Sciences for a Healthier EU.
- Published in:
- World Medical Journal, 2015, v. 61, n. 1, p. 22
- By:
- Publication type:
- Article
The Innovative Medicines Initiative: an engine for regulatory science.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 1, doi. 10.1038/nrd4520
- By:
- Publication type:
- Article
NEWMEDS special issue commentary.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Regulatory Writing.
- Published in:
- Medical Writing, 2013, v. 22, n. 4, p. 301, doi. 10.1179/2047480613Z.000000000159
- By:
- Publication type:
- Article
Sunshine spreading across the Atlantic and Over Europe.
- Published in:
- Medical Writing, 2013, v. 22, n. 4, p. 248, doi. 10.1179/2047480613Z.000000000143
- By:
- Publication type:
- Article
Asthma phenotyping: noninvasive biomarkers suitable for bedside science are the next step to implement precision medicine.
- Published in:
- 2016
- By:
- Publication type:
- commentary
Infectious disease leads in first phase of Europe's IMI effort.
- Published in:
- Nature Medicine, 2014, v. 20, n. 1, p. 5, doi. 10.1038/nm0114-5
- Publication type:
- Article
Transparency battle resurfaces as EU trial revamp wraps up.
- Published in:
- Nature Medicine, 2013, v. 19, n. 7, p. 797, doi. 10.1038/nm0713-797
- By:
- Publication type:
- Article
Public-private partnerships need honest brokering.
- Published in:
- 2012
- By:
- Publication type:
- Opinion